<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01963299</url>
  </required_header>
  <id_info>
    <org_study_id>GIRARD-BERTRAND 2013</org_study_id>
    <nct_id>NCT01963299</nct_id>
  </id_info>
  <brief_title>Clonidine - Ropivacaine in Peribulbar Anesthesia</brief_title>
  <acronym>CRAPO</acronym>
  <official_title>Prospective Randomised Double-blind Study to Compare Ropivacaine 10mg/mL Alone Versus Ropivacaine 10mg/mL Associated With Clonidine 1µg/kg for Peribulbar Anesthesia in Posterior Eye Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study conducted in 60 patients, randomly assigned to one of two groups of 30: the
      first will receive ropivacaine alone and the second will receive the association
      ropivacaine/clonidine.

      The aim of the study is to prove that the association of Clonidine with Ropivacaine is more
      effective than ropivacaine alone for locoregional anaesthesia of the eye for retinal surgery.

      The principal interest of this association of drugs is that it procures faster and longer
      anaesthesia of the eye with less ropivacaine (therefore fewer injections). This provides
      greater comfort to the patient during and after the intervention.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dose of ropivacaine injected 10 mg/ml: necessary to obtain complete ocular akinesia</measure>
    <time_frame>up to 1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to achieve akinesia</measure>
    <time_frame>up to 1 hour</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Indication for Surgery of the Posterior Segment Under Locoregional Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Ropivacaine alone group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine/Clonidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5 ml Ropivacaine 10% + physiological saline</intervention_name>
    <arm_group_label>Ropivacaine alone group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5 ml Ropivacaine 10% + Clonidine 1 µg/kg</intervention_name>
    <arm_group_label>Ropivacaine/Clonidine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who have given written informed consent

          -  any adult patient about to undergo their first operation involving the posterior
             segment of the eye under peribulbar anaesthesia

        Exclusion Criteria:

          -  persons without National Health Insurance

          -  pregnant or breast-feeding women, patients &lt; 18, patients who cannot give their
             consent, patient's refusal of Loco-Regional Anesthesia, patients who cannot remain in
             dorsal decubitus dorsal for at least 1h

          -  contra-indication for Loco-Regional Anesthesia

          -  hypersensitivity to the study drugs (ropivacaine, clonidine), to the corresponding
             excipients or hypersensitivity to local anaesthetics other than amide-type
             ropivacaine.

          -  disorders of periorbital or oculomotor sensitivity, patients with glaucoma, patients
             with chronic pain and on morphines

          -  uncontrolled arterial hypertension, clonidine per os at home, arterial hypotension
             before the intervention (SAP &lt; 90 mmHg)

          -  Surgery for diabetic retinopathy, patients with unbalanced diabetes, eye with prior
             posterior segment surgery

          -  Contra-indications mentioned on the summary of product characteristics for clonidine
             (known hypersensitivity to the active ingredients or one of its excipients, Heart rate
             below 60bpm, severe Bradycardia due to sinoatrial node disease or second or third
             degree atrioventricular block, Depression, Sultopride).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2013</study_first_submitted>
  <study_first_submitted_qc>October 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2013</study_first_posted>
  <last_update_submitted>October 11, 2013</last_update_submitted>
  <last_update_submitted_qc>October 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

